XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statement of Equity - USD ($)
Total
Common stock
Retained earnings
Noncontrolling interests
Balance, Beginning of Period at Dec. 31, 2019 $ 51,085,253 $ 49,914,478 $ 1,208,395 $ (37,620)
Balance, Beginning of Period (in shares) at Dec. 31, 2019   15,263,555    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation 264,574 $ 264,574    
Share-based compensation (in shares)   219,850    
Repurchase of common shares (441,624) $ (441,624)    
Repurchase of shares (in shares)   (164,866)    
Net income (loss) (1,065,145)   (1,055,620) (9,525)
Balance, End of Period at Mar. 31, 2020 49,843,058 $ 49,737,428 152,775 (47,145)
Balance, End of Period (in shares) at Mar. 31, 2020   15,318,539    
Balance, Beginning of Period at Dec. 31, 2020 $ 46,873,394 $ 49,121,523 (2,131,013) (117,116)
Balance, Beginning of Period (in shares) at Dec. 31, 2020 14,988,429 14,988,429    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation $ 162,960 $ 162,960    
Share-based compensation (in shares)   187,759    
Repurchase of common shares (303,088) $ (303,088)    
Repurchase of shares (in shares)   (91,724)    
Net income (loss) 144,661   166,828 (22,167)
Balance, End of Period at Mar. 31, 2021 $ 46,877,927 $ 48,981,395 $ (1,964,185) $ (139,283)
Balance, End of Period (in shares) at Mar. 31, 2021 15,084,464 15,084,464